The albumin-based hydrogel constructed by Chen et al. has a cumulative release rate of ∼25% DOX within 24 h, and the remaining drug is able to be released sustainably for about 10 days, the hydrogel showed good therapeutic effects for tumor-bearing mice (The highest tumor-inhibition rate of 93.1% was achieved compared to the control group). This evidence concerns the gene ALB and neoplasm.